Brief

On 09/12/2024, the Therapeutic Goods Administration (TGA) issued an update regarding Updates to requirements and guidance for labels of injectable medicines. The TGA has made changes to Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines (TGO 91) to clarify quantities of active ingredients on medicine labels for health professionals, particularly for injectable electrolyte replacement medicines with a volume of 100 mL or less.

This content is restricted.

Highlights content goes here...

This content is restricted.

Therapeutic Goods Administration (TGA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies